Physician profile
Andre Small
NPI 1043708969
$3,237.14
in general payments reported to CMS, 2019-2025
24 companies · $953 in 2025
The $953 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $349 · 2023: $663 · 2024: $1,272 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,888.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,104.09 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $350.05 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $281.51 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Pfizer INC. | $226.28 | 2023-2025 | |
| Glaxosmithkline, LLC. | $201.24 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Amgen INC. | $188.73 | 2023-2025 | Repatha, Otezla, Krystexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.63 | 2022-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $132.94 | 2022-2025 | Veozah |
| Abbvie INC. | $121.09 | 2023-2024 | Synthroid, Rinvoq |
| Exact Sciences Corporation | $117.60 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $63.62 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.72 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.35 | 2022 | |
| Phathom Pharmaceuticals, INC. | $25.52 | 2024 | Voquezna |
| Corcept Therapeutics | $24.03 | 2024 | Korlym |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $20.01 | 2023 | Loreev Xr |
| Xeris Pharmaceuticals, INC. | $18.40 | 2025 | Keveyis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.09 | 2024 | Jardiance |
| Idorsia Pharmaceuticals US INC | $16.48 | 2023 | Quviviq |
| Dexcom, INC. | $15.80 | 2025 | Dexcom G6 Transmitter |
| Inogen, INC. | $15.74 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Intra-Sana Laboratories | $14.38 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Esperion Therapeutics, INC. | $14.20 | 2024 | Nexletol |
| Optos, INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.